Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors

Translational Oncology

Volumn 6, Issue 6, 2013, Pages 722-731

  Joh, Daniel Y ^a   Kao, Gary D ^a   Murty, Surya ^a   Stangl, Melissa ^a   Sun, Lova ^a   Zaki, Ajlan Al ^b   Xu, Xiangsheng ^a   Hahn, Stephen M ^a   Tsourkas, Andrew ^b   Dorsey, Jay F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891693960     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13433     Document Type: Article

References (49)

1. American Cancer Society (2012). Cancer Facts & Figures 2012, Atlanta, GA: American Cancer Society.
2. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, Delaney T, Glatstein E, Steinberg SM, Merino MJ, et al. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16, 197-203.
3. Pisters PWT, Harrison LB, Leung DHY, Woodruff JM, Casper ES, and Brennan MF (1996). Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14, 859-868.
4. Koshy M, Rich SE, and Mohiuddin MM (2010). Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys 77, 203-209.
5. Zhou Z, McDade TP, Simons JP, Ng SC, Lambert LA, Whalen GF, Shah SA, and Tseng JF (2010). Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg 145, 426-431.
6. Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen Y-LE, et al. (2011). Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys 81, e775-e780.
7. Clark MA, Fisher C, Judson I, and Thomas JM (2005). Soft-tissue sarcomas in adults. N Engl J Med 353, 701-711.
8. Wesolowski R and Budd GT (2010). Use of chemotherapy for patients with bone and soft-tissue sarcomas. Cleve Clin J Med 77, S23-S26.
9. Demas BE, Heelan RT, Lane J, Marcove R, Hajdu S, and Brennan MF (1988). Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease. AJR Am J Roentgenol 150, 615-620.
10. Biau DJ, Ferguson PC, Chung P, Griffin AM, Catton CN, O'Sullivan B, and Wunder JS (2012). Local recurrence of localized soft tissue sarcoma: a new look at old predictors. Cancer 118, 5867-5877.
11. Weitz J, Antonescu CR, and Brennan MF (2003). Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol 21, 2719-2725.
12. Cai Q-Y, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, Park SH, Juhng SK, and Yoon K-H (2007). Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol 42, 797-806.
13. Jackson PA, Abd Rahman WNW, Wong CJ, Ackerly T, and Geso M (2010). Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents. Eur J Radiol 75, 104-109.
14. Kumagai M, Sarma TK, Cabral H, Kaida S, Sekino M, Herlambang N, Osada K, Kano MR, Nishiyama N, and Kataoka K (2010). Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol Rapid Commun 31, 1521-1528.
15. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, et al. (2012). A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18, 829-834.
16. Iyer AK, Khaled G, Fang J, and Maeda H (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11, 812-818.
17. Shuaidong H, Ma H, Huang K, Liu J, Wei T, Jin S, Zhang J, He S, and Liang X-J (2012). Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res 73, 319-330.
18. Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, and Kreyline WG (2010). Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31, 6574-6581.
19. Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, Bristow RG, Hill RP, and Jaffray DA (2010). Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173, 719-728.
20. Butterworth KT, Coulter JA, Jain S, Forker J, McMahon SJ, Schettino G, Prise KM, Currell FJ, and Hirst DG (2010). Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 21, 295101.
21. Liu C-J, Wang C-H, Chen S-T, Chen H-H, Leng W-H, Chien C-C, Wang C-L, Kempson IM, Hwu Y, Lai T-C, et al. (2010). Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 55, 931-945.
22. Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X, Chen J, et al. (2009). Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 20, 375101.
23. Zhang X-D, Wu D, Shen X, Chen J, Sun Y-M, Liu P-X, and Liang X-J (2012). Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33, 6408-6419.
24. Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, et al. (2011). Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys 79, 531-539.
25. Chang M-Y, Shiau A-L, Chen Y-H, Chang C-J, Chen HHW, and Wu C-L (2008). Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumorbearing mice. Cancer Sci 99, 1479-1484.
26. Wencai X, Luo T, Bo P, Ping L, Zhou C, Peng H, Chunlei Z, Ren Q, Hu W, and Shen F (2012). The radiosensitization of melanoma cells by gold nanorods irradiated with MV X-ray. Nano Biomed Eng 4, 6-11.
27. Polf JC, Bronk LF, Driessen WHP, Arap W, Pasqualini R, and Gillin M (2011). Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles. Appl Phys Lett 98, 193702.
28. Kim J-K, Seo S-J, Kim K-H, Kim T-J, Chung M-H, Kim K-R, and Yang T-K (2010). Therapeutic application of metallic nanoparticles combined with particleinduced x-ray emission effect. Nanotechnology 21, 425102.
29. Berbeco RI, Korideck H, Ngwa W, Kumar R, Patel J, Sridhar S, Johnson S, Price BD, Kimmelman A, and Makrigiorgos GM (2012). DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res 178, 604-608.
30. Chattopadhyay N, Cai Z, Kwon Y, Lechtman E, Pignol J-P, and Reilly R (2013). Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat 137, 81-91.
31. Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, and Mao H (2010). EGFRVIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res 70, 6303-6312.
32. Zhang X-D, Wu D, Shen X, Liu P-X, Yang N, Zhao B, Zhang H, Sun Y-M, Zhang L-A, and Fan F-Y (2011). Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine 6, 2071-2081.
33. Hainfeld JF, Smilowitz HM, O'Connor MJ, Dilmanian FA, and Slatkin DN (2012). Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond) 8, 1601-1609.
34. Hainfeld JF, Slatkin DN, and Smilowitz HM (2004). The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49, N309-N315.
35. Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, and Plech A (2006). Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 110, 15700-15707.
36. Haiss W, Thanh NTK, Aveyard J, and Fernig DG (2007). Determination of size and concentration of gold nanoparticles from UV-Vis spectra. Anal Chem 79, 4215-4221.
37. Wong J, Armour E, Kazanzides P, Iordachita U, Tryggestad E, Deng H, Matinfar M, Kennedy C, Liu Z, Chan T, et al. (2008). High-resolution, small animal radiation research platform with X-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys 71, 1591-1599.
38. Mayer G, Leone RD, Hainfeld JF, and Bendayan M (2000). Introduction of a novel HRP substrate-nanogold probe for signal amplification in immunocytochemistry. J Histochem Cytochem 48, 461-469.
39. Sedelnikova OA, Pilch DR, Redon C, and Bonner WM (2003). Histone H2AX in DNA damage and repair. Cancer Biol Ther 2, 233-235.
40. Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C, Davidson R, and Geso M (2009). Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 5, 136-142.
41. Butterworth KT, McMahon SJ, Currell FJ, and Prise KM (2012). Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 4, 4830-4838.
42. Cheng NN, Starkewolf Z, Davidson RA, Sharmah A, Lee C, Lien J, and Guo T (2012). Chemical enhancement by nanomaterials under X-ray irradiation. J Am Chem Soc 134, 1950-1953.
43. McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, Schettino G, Dickson GR, Hounsell AR, O'Sullivan JM, et al. (2011). Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep 1, 18.
44. Prise KM, Schettino G, Folkard M, and Held KD (2005). New insights on cell death from radiation exposure. Lancet Oncol 6, 520-528.
45. Hainfeld JF, Dilmanian FA, Slatkin DN, and Smilowitz HM (2008). Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 60, 977-985.
46. Kommareddy S and Amiji M (2007). Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharm Sci 96, 397-407.
47. Soyfer V, Corn BW, Kollender Y, Issakov J, Dadia S, Flusser G, Bickels J, Meller I, and Merimsky O (2013). Hypofractionated adjuvant radiation therapy of softtissue sarcoma achieves excellent results in elderly patients. Br J Radiol 86, 24.
48. Pricker S (1996). Medical uses of gold compounds: past, present and future. Gold Bull 29, 53-60.
49. Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, and Tamarkin L (2010). Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16, 6139-6149.